Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/343787
COMPARTIR / EXPORTAR:
SHARE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | New Pieces for an Old Puzzle: Approaching Parkinson’s Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics |
Autor: | Ortega Moreno, L.; Bagues, Ana; Martínez, V.; Abalo, Raquel CSIC ORCID | Palabras clave: | animal models constipation Dopamine gastrointestinal Gut-brain axis lipidome microbiota Non-motor symptoms Parkinson’s disease Probiotics |
Fecha de publicación: | 2023 | Editor: | Multidisciplinary Digital Publishing Institute | Citación: | Nutrients 15 (2023) | Resumen: | Parkinson’s disease (PD) is a severe neurodegenerative disease characterized by disabling motor alterations that are diagnosed at a relatively late stage in its development, and non-motor symptoms, including those affecting the gastrointestinal tract (mainly constipation), which start much earlier than the motor symptoms. Remarkably, current treatments only reduce motor symptoms, not without important drawbacks (relatively low efficiency and impactful side effects). Thus, new approaches are needed to halt PD progression and, possibly, to prevent its development, including new therapeutic strategies that target PD etiopathogeny and new biomarkers. Our aim was to review some of these new approaches. Although PD is complex and heterogeneous, compelling evidence suggests it might have a gastrointestinal origin, at least in a significant number of patients, and findings in recently developed animal models strongly support this hypothesis. Furthermore, the modulation of the gut microbiome, mainly through probiotics, is being tested to improve motor and non-motor symptoms and even to prevent PD. Finally, lipidomics has emerged as a useful tool to identify lipid biomarkers that may help analyze PD progression and treatment efficacy in a personalized manner, although, as of today, it has only scarcely been applied to monitor gut motility, dysbiosis, and probiotic effects in PD. Altogether, these new pieces should be helpful in solving the old puzzle of PD. | Versión del editor: | http://dx.doi.org/10.3390/nu15122775 | URI: | http://hdl.handle.net/10261/343787 | Identificadores: | doi: 10.3390/nu15122775 issn: 2072-6643 |
Aparece en las colecciones: | (IQM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
nutrients-15-02775.pdf | 1,11 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
Este item está licenciado bajo una Licencia Creative Commons